2-196306451-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001348768.2(HECW2):​c.2814+37G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.748 in 1,567,756 control chromosomes in the GnomAD database, including 441,951 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 38882 hom., cov: 31)
Exomes 𝑓: 0.75 ( 403069 hom. )

Consequence

HECW2
NM_001348768.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.721

Publications

9 publications found
Variant links:
Genes affected
HECW2 (HGNC:29853): (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2) This gene encodes a member of a family of E3 ubiquitin ligases which plays an important role in the proliferation, migration and differentiation of neural crest cells as a regulator of glial cell line-derived neurotrophic factor (GDNF)/Ret signaling. This gene also plays an important role in angiogenesis through stabilization of endothelial cell-to-cell junctions as a regulator of angiomotin-like 1 stability. The encoded protein contains an N-terminal calcium/lipid-binding (C2) domain involved in membrane targeting, two-four WW domains responsible for cellular localization and substrate recognition, and a C-terminal homologous with E6-associated protein C-terminus (HECT) catalytic domain. Naturally occurring mutations in this gene are associated with neurodevelopmental delay, hypotonia, and epilepsy. The decreased expression of this gene in the aganglionic colon is associated with Hirschsprung's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
HECW2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
  • neurodevelopmental disorder with hypotonia, seizures, and absent language
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 2-196306451-C-T is Benign according to our data. Variant chr2-196306451-C-T is described in ClinVar as Benign. ClinVar VariationId is 1285333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.945 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HECW2NM_001348768.2 linkc.2814+37G>A intron_variant Intron 13 of 28 ENST00000644978.2 NP_001335697.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HECW2ENST00000644978.2 linkc.2814+37G>A intron_variant Intron 13 of 28 NM_001348768.2 ENSP00000495418.1 Q9P2P5-1

Frequencies

GnomAD3 genomes
AF:
0.707
AC:
107269
AN:
151730
Hom.:
38865
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.544
Gnomad AMI
AF:
0.824
Gnomad AMR
AF:
0.790
Gnomad ASJ
AF:
0.768
Gnomad EAS
AF:
0.968
Gnomad SAS
AF:
0.754
Gnomad FIN
AF:
0.776
Gnomad MID
AF:
0.671
Gnomad NFE
AF:
0.749
Gnomad OTH
AF:
0.729
GnomAD2 exomes
AF:
0.766
AC:
171977
AN:
224648
AF XY:
0.764
show subpopulations
Gnomad AFR exome
AF:
0.530
Gnomad AMR exome
AF:
0.846
Gnomad ASJ exome
AF:
0.763
Gnomad EAS exome
AF:
0.978
Gnomad FIN exome
AF:
0.782
Gnomad NFE exome
AF:
0.745
Gnomad OTH exome
AF:
0.748
GnomAD4 exome
AF:
0.752
AC:
1065335
AN:
1415908
Hom.:
403069
Cov.:
25
AF XY:
0.753
AC XY:
528890
AN XY:
702416
show subpopulations
African (AFR)
AF:
0.526
AC:
16694
AN:
31724
American (AMR)
AF:
0.837
AC:
32989
AN:
39432
Ashkenazi Jewish (ASJ)
AF:
0.761
AC:
18700
AN:
24576
East Asian (EAS)
AF:
0.954
AC:
36364
AN:
38132
South Asian (SAS)
AF:
0.748
AC:
60265
AN:
80528
European-Finnish (FIN)
AF:
0.775
AC:
40705
AN:
52522
Middle Eastern (MID)
AF:
0.695
AC:
3876
AN:
5576
European-Non Finnish (NFE)
AF:
0.748
AC:
811700
AN:
1084966
Other (OTH)
AF:
0.753
AC:
44042
AN:
58452
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
10724
21447
32171
42894
53618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19978
39956
59934
79912
99890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.707
AC:
107338
AN:
151848
Hom.:
38882
Cov.:
31
AF XY:
0.711
AC XY:
52790
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.544
AC:
22508
AN:
41402
American (AMR)
AF:
0.790
AC:
12060
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.768
AC:
2666
AN:
3470
East Asian (EAS)
AF:
0.967
AC:
4994
AN:
5162
South Asian (SAS)
AF:
0.754
AC:
3623
AN:
4808
European-Finnish (FIN)
AF:
0.776
AC:
8167
AN:
10524
Middle Eastern (MID)
AF:
0.667
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
0.749
AC:
50842
AN:
67910
Other (OTH)
AF:
0.729
AC:
1534
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1510
3020
4530
6040
7550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.722
Hom.:
7946
Bravo
AF:
0.702
Asia WGS
AF:
0.833
AC:
2893
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neurodevelopmental disorder with hypotonia, seizures, and absent language Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.049
DANN
Benign
0.67
PhyloP100
-0.72
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4241189; hg19: chr2-197171175; API